Sea Crest Wealth Management, LLC Collegium Pharmaceutical, Inc Transaction History

Sea Crest Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 10, 2019	SELL	$13.58 - $18.72 $20,370 - $28,080	-1,500 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$14.78 - $19.68 $14,780 - $19,680	1,000 Added 200.0%	1,500 $26,000
Q3 2018 Nov 14, 2018	SELL	$14.16 - $24.3 $1,416 - $2,430	-100 Reduced 16.67%	500 $7,000
Q2 2018 Aug 03, 2018	SELL	$21.79 - $28.29 $27,237 - $35,362	-1,250 Reduced 67.57%	600 $14,000
Q1 2018 Apr 20, 2018	SELL	$18.15 - $29.21 $11,797 - $18,986	-650 Reduced 26.0%	1,850 $47,000
Q4 2017 Feb 02, 2018	BUY	$9.3 - $19.14 $23,250 - $47,850	2,500	2,500 $46,000

249

36.2M

100K

21.1K

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.11B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

Get notified when there are updates to the investment portfolio of Sea Crest Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sea Crest Wealth Management, LLC with notifications on news.